Detection of neuroendocrine tumors: 99mTc-P829 scintigraphy compared with 111In-pentetreotide scintigraphy

R Lebtahi, J Le Cloirec, C Houzard… - Journal of Nuclear …, 2002 - Soc Nuclear Med
The aim of this study was to evaluate the diagnostic value of a new somatostatin analog,
99mTc-P829, compared with that of 111In-pentetreotide. Methods: Forty-three patients (32 …

Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging.

W Shi, CF Johnston, KD Buchanan… - QJM: monthly journal …, 1998 - academic.oup.com
A wide variety of neuroendocrine tumours express somatostatin receptors, and can be
visualized by radiolabelled somatostatin analogue scintigraphy. To investigate the value of …

An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors

M Gabriel, C Decristoforo, E Donnemiller… - Journal of nuclear …, 2003 - Soc Nuclear Med
The aim of this study was to compare the imaging abilities of the recently developed
somatostatin analog, 99mTc-hydrazinonicotinyl-Tyr3-octreotide (99mTc-HYNIC-TOC [99mTc …

[PDF][PDF] Neuroendocrine tumors and somatostatin: imaging techniques

WW De Herder, DJ Kwekkeboom, R Valkema… - J Endocrinol …, 2005 - researchgate.net
Tumors and metastases bearing the somatostatin receptor subtypes 2 (SSTR2) or SSTR5
can be visualized in vivo after injection of radiolabeled octapeptide somatostatin analogs …

Imaging neuroendocrine tumours with radiolabelled somatostatin analogues and X-ray computed tomography: a comparative study

CMP King, RH Reznek, J Bomanji, E Ur, KE Britton… - Clinical radiology, 1993 - Elsevier
Various endocrine neoplasms, including a number of carcinoid and pancreatic islet cell
tumours, express somatostatin receptors. These tumours may be difficult to localize using …

Somatostatin receptor imaging of neuroendocrine tumors with indium-111 pentetreotide (Octreoscan)

JO Olsen, RV Pozderac, G Hinkle, T Hill… - Seminars in nuclear …, 1995 - Elsevier
Somatostatin, a naturally occurring 14-amino acid peptide, can be thought of as an anti-
growth hormone and functional down-regulator of sensitive tissue. Most neuroendocrine …

Contribution of 111In-pentetreotide SPECT/CT imaging to conventional somatostatin receptor scintigraphy in the detection of neuroendocrine tumours

A Sainz-Esteban, R Olmos… - Nuclear medicine …, 2015 - journals.lww.com
Aim The aim of the study was to assess the contribution of 111 In-pentetreotide single-
photon emission computed tomography/computed tomography (SPECT/CT) imaging to …

Localization of neuroendocrine tumours and insulinomas using radiolabeled somatostatin analogues, 123 I‐Try3‐octreotide and 111in‐pentatreitide

E Ur, J Bomanji, SJ Mather, KE Britton… - Clinical …, 1993 - Wiley Online Library
OBJECTIVE A number of neoplasms are known to express somatostatin receptors; the use
of somatostatin receptor imaging in their localization has recently been described, but the …

Somatostatin receptor scintigraphy with 111In-pentetreotide in non-functioning gastroenteropancreatic neuroendocrine tumors

O Schillaci, A Spanu, F Scopinaro… - International …, 2003 - spandidos-publications.com
To investigate somatostatin receptor scintigraphy (SRS) usefulness compared to
conventional imaging procedures (CIP) in non-functioning gastroenteropatic (GEP) …

Somatostatin receptor imaging in the diagnosis and treatment of neuroendocrine tumors

SWJ Lamberts, JC Reubi, EP Krenning - The Journal of Steroid …, 1992 - Elsevier
Somatostatin analogs are used in the control of hormonal hypersecretion and tumor growth
of patients with acromegaly, islet cell carcinomas and carcinoids. Recently we showed that …